63. 特発性血小板減少性紫斑病 Idiopathic thrombocytopenic purpura Clinical trials / Disease details
臨床試験数 : 363 / 薬物数 : 212 - (DrugBank : 43) / 標的遺伝子数 : 47 - 標的パスウェイ数 : 138
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05220878 (ClinicalTrials.gov) | September 9, 2021 | 21/1/2022 | Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With Chronic ITP | Multicenter Randomized Double-blind Comparative Study of Clinical Efficacy and Safety of GNR-069 (JSC GENERIUM, Russia) and Nplate (Amgen Europe BV, The Netherlands) in Patients With Chronic Idiopathic Thrombocytopenic Purpura | Idiopathic Thrombocytopenic Purpura | Biological: GNR-069;Biological: Nplate | AO GENERIUM | NULL | Recruiting | 18 Years | 75 Years | All | 160 | Phase 3 | Russian Federation |